reference/4432533

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4432533

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	20
issn	1423-0232 0030-2414
issueIdentifier	1-2
pageRange	9-20
publicationName	Oncology
startingPage	9
bibliographicCitation	Underhill C, Goldstein D, Gorbounova VA, Biakhov MY, Bazin IS, Granov DA, Hossain AM, Blatter J, Kaiser C, Ma D. A randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer. Oncology. 2007;73(1-2):9–20. doi: 10.1159/000120626. PMID: 18334829.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a72fc0addc41baad72061771356d34d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39fcccb577372d10c612d8f04c380bbd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7ce8389e274c47c427c631d5b27f2b6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fea039945c7e95bec911e0b9ed908ac1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62bd5709fcc5222a4f8b6684a98a94de http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4cf4956309e19dea962fbc2ad39c3acc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_569ab65fb5b7a64a61851c92334eb283 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_067aecc81a1a5e8b86a2b3b9540dddad http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1fdc274b42f5e13262a6465d8cb7983 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_136d4b3b6ff00883d9085485418e4f14
date	2007
identifier	https://doi.org/10.1159/000120626 https://pubmed.ncbi.nlm.nih.gov/18334829
isPartOf	https://portal.issn.org/resource/ISSN/1423-0232 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6265 https://portal.issn.org/resource/ISSN/0030-2414
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A Randomized Phase II Trial of Pemetrexed plus Irinotecan (ALIRI) versus Leucovorin-Modulated 5-FU plus Irinotecan (FOLFIRI) in First-Line Treatment of Locally Advanced or Metastatic Colorectal Cancer
discusses	http://id.nlm.nih.gov/mesh/M0003242 http://id.nlm.nih.gov/mesh/M0356369 http://id.nlm.nih.gov/mesh/M0147530 http://id.nlm.nih.gov/mesh/M0004519 http://id.nlm.nih.gov/mesh/M0227083 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0009679 http://id.nlm.nih.gov/mesh/M0001486 http://id.nlm.nih.gov/mesh/M0018076 http://id.nlm.nih.gov/mesh/M0001471 http://id.nlm.nih.gov/mesh/M0009376 http://id.nlm.nih.gov/mesh/M0008631
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002288Q000188 http://id.nlm.nih.gov/mesh/D000230Q000188 http://id.nlm.nih.gov/mesh/D015179Q000473 http://id.nlm.nih.gov/mesh/D015179Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D014408Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000964Q000008 http://id.nlm.nih.gov/mesh/D005971Q000008 http://id.nlm.nih.gov/mesh/D000077146 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D000230Q000556 http://id.nlm.nih.gov/mesh/D014408Q000235 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D002166Q000031 http://id.nlm.nih.gov/mesh/D002166Q000008 http://id.nlm.nih.gov/mesh/D005472Q000008 http://id.nlm.nih.gov/mesh/D011237 http://id.nlm.nih.gov/mesh/D006147Q000008 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D002288Q000556 http://id.nlm.nih.gov/mesh/D015179Q000378 http://id.nlm.nih.gov/mesh/D042461Q000378 http://id.nlm.nih.gov/mesh/D006147Q000031 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D000068437 http://id.nlm.nih.gov/mesh/D011623Q000378 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D000972Q000008 http://id.nlm.nih.gov/mesh/D020133 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D020080 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D020641 http://id.nlm.nih.gov/mesh/D015972 http://id.nlm.nih.gov/mesh/D002955Q000008 http://id.nlm.nih.gov/mesh/D009367
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136170999 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135403648 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135436482 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60838 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453

Incoming Links

Predicate

Subject

http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID76715706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136058681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128999113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129439837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129520161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129430288

Total number of triples: 102.